Cargando…
Mouse Sertoli Cells Inhibit Humoral-Based Immunity
Transplantation is used to treat many different diseases; however, without the use of immunosuppressants, which can be toxic to the patient, grafted tissue is rejected by the immune system. Humoral immune responses, particularly antibodies and complement, are significant components in rejection. Rem...
Autores principales: | Washburn, Rachel L., Kaur, Gurvinder, Dufour, Jannette M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656144/ https://www.ncbi.nlm.nih.gov/pubmed/36361551 http://dx.doi.org/10.3390/ijms232112760 |
Ejemplares similares
-
Sertoli Cell Immune Regulation: A Double-Edged Sword
por: Washburn, Rachel L., et al.
Publicado: (2022) -
Immunoregulatory Sertoli Cell Allografts Engineered to Express Human Insulin Survive Humoral-Mediated Rejection
por: Washburn, Rachel L., et al.
Publicado: (2022) -
An overview of a Sertoli cell transplantation model to study testis morphogenesis and the role of the Sertoli cells in immune privilege
por: Kaur, Gurvinder, et al.
Publicado: (2017) -
Complementing Testicular Immune Regulation: The Relationship between Sertoli Cells, Complement, and the Immune Response
por: Washburn, Rachel L., et al.
Publicado: (2023) -
Genetically engineered immune privileged Sertoli cells: A new road to cell based gene therapy
por: Kaur, Gurvinder, et al.
Publicado: (2012)